Phase Forward's InForm a Wise Choice for Cancer Center


By Deborah Borfitz

Dana Farber/Harvard Cancer Center (DF/HCC) is undertaking its first sizeable investigator-initiated trial (IIT) using Phase Forward's InForm electronic data capture (EDC) product. So far, it's going surprisingly smooth, says Marina Nillni, EDC implementation program manager. "We went live November 15, 2006 and I have heard nothing about it. I'm the technical support contact person, so that means things are working."

The Phase III pediatric acute lymphoblastic leukemia (ALL) study, which started on paper in January 2005, will ultimately involve more than 500 patients at nine centers in Canada, Puerto Rico, and the U.S. Currently, about 159 patients are enrolled at eight sites with an average of two clinical research coordinators (CRCs) per site doing data entry, says Nillni. "The concern, initially, was that we would have trouble training and supporting remote sites and that has not been an issue."

DF/HCC is a consortium of five Harvard-affiliated institutions created with funding from the National Cancer Institute and is the nation's largest oncology center. In 2005, it standardized on InForm for all its IITs after a rigorous evaluation process that measured 12 EDC vendors against 173 weighted criteria, says Nillni. About 60 IITs were initiated in 2006, accounting for about 25 percent of all new oncology studies done by DF/HCC. Approximately 230 IITs are ongoing at any time.

After signing the contract with Phase Forward, DF/HCC spent the next eight months on set-up and training. Between October 2005 and November 2006, DF/HCC launched 12 small phase II gastrointestinal and breast cancer studies using InForm to "get familiar with the product," says Nillni. Each study accrued between 30 and 60 patients. The folks in IT and data management were completely unfamiliar with InForm.

The initial studies went "very well," says Nillni. Data already produced on paper for the ALL study was back loaded into InForm, a process that required about 40 hours. "CRCs really liked [InForm] and data managers were very happy." According to one CRC, a GI investigator was so impressed with InForm's real-time reporting capabilities that he decided to use EDC for all of his future studies. With paper, he was waiting four weeks to get study data.

Phase Forward was selected as EDC vendor over three other finalists: Oracle Clinical, Medidata, and Velos. At the time, each had key weaknesses that took it out of the running, says Nillni. "With Oracle Clinical, the remote data capture product was not very functional." Further, the product wasn't Web-based. "We would have had to purchase laptops for all users and install a heavy client into each machine." Customer service was also a downside. That Oracle Clinical works with both paper and EDC was irrelevant to DF/HCC. "We don't do hybrid trials."

With Medidata Rave, the problems were an infrastructure based on Microsoft Sequel Server and "out of reach" pricing. Velos, like Oracle Clinical, had an immature EDC product. It was also a small firm and "we wanted to work with a more secure, more established company." The other contenders were DataLabs, Datatrack, Enmed, eRT, etrials, FirstGeneticTrust, LifeTree Technology, and Percipenz.

Development of the selection criteria was a nine-month team effort involving information systems, data management, a biostatistics representative, and clinical teams, says Nillni. Among the 31 "must haves" were a library of data items, eCRF version tracking, centralized system upgrades, and the ability to import data from multiple external lab systems.

Subscribe to Bio-IT World  magazine.

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

definiens briefingon-76Next-Generation Technologies Revolutionizing Oncology and Diagnostics
underwritten by Definiens

This “Briefing On” collection of Bio-IT World features, commentaries and analysis, presents some of the latest thinking on high-throughput technologies that are being applied to the fields of research and drug discovery, with particular emphasis on oncology, diagnostics and imaging technologies. Download now at no charge compliments of the underwriting sponsor, Definiens. Download This Free Paper



gq nxt gen seq

This Bio•IT World Briefing On “Next-Generation Sequencing,” underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data.  Download now 



metaminerMetaMiner™ Cystic Fibrosis Report
Sponsored by GeneGo

This paper discusses the MetaMiner™ (CF) data analysis platform for a broad range of CF researchers designed to:

1. Easily assemble important biological and chemical experimental data available today in cystic fibrosis research.
2. Visualize key mechanisms leading to the disease through pathway maps and network models.
3. Provide the CF community a “one stop shop” tool for uploading and analyzing experimental data in a disease-centered interface.
Download Now

 



Life Science Webcasts & Podcasts

GenoLogicsgenologics 2 translational
Enabling Translational Research Informatics

Learn about the challenges facing life sciences research labs to manage their translational research data:

  • The trends for organizations to adopt informatics solutions for translational research.
  • The unique requirements with managing complex data and workflow.
  • What labs should consider when reviewing informatics solutions for translational research.
  • Which life sciences research organizations are successfully adopting an informatics solution.

Download Now



More Podcasts

Job Openings

Assistant Editor (Science Writer)~Cambridge Healthtech Institute (CHI), Needham, MA, 
Cambridge Healthtech Institute seeks an assistant editor (science writer) who is an ambitious, dependable journalist who can fulfill a range of writing and editorial duties for a series of eNewsletters covering various aspects of the biopharmaceutical industry in addition to CHI’s flagship publication, Bio-IT World magazine.  This is a superb opportunity to make important contributions to the growth and success of a multimedia science publishing group, while gaining invaluable experience in multiple facets of the publishing industry.   Interested candidates should submit a cover letter, including 3 writing samples (attached in Word or PDF format), salary history or requirements, and resume to kdavies@healthtech.com. For a detailed description of the Assistant Editor position, please click here.

Fred Hutchinson Cancer Research Center: IT Business Analyst III
The Hutchinson Center is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Through our Tumor Research Initiative, we are finding new ways to detect tumors at an early stage.  We are presently seeking an experienced IT Business Analyst to assess technology needs for the Tumor Research Initiative, and to identify and design improvements to computer based systems.  For more information please visit www.fhcrc.org and search for Job# AD-21465

For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to bio-itworld@theygsgroup.com.